OABI OmniAb Inc
204
$4.38
$0.01
(0.23%)
| Watchers | 204 |
| 52-Wk Low | $3.98 |
| 52-Wk High | $6.72 |
| Market Cap | $514.18M |
| Volume | 121.00 |
| 52-Wk High | $6.72 |
| 52-Wk Low | $3.98 |
OmniAb to Participate in the Jefferies Global Healthcare ConferenceBusiness Wire • 1 day ago
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City...
Share to Feed
OmniAb, Inc. (Nasdaq: OABI) today announced its participation in the 20th Annual PEGS Boston The Essential Protein & Antibody Engineering Summit underway at the Omni Hotel. Earlier today the Company...
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2024, and provided operating and partner program updates. The OmniAb team continued to make great...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May. RBC Capital Markets Global Healthcare Conference, May 14-15 at...
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Thursday, May 9, 2024 and will hold a conference...
OmniAb, Inc. (NASDAQ:OABI Free Report) Research analysts at HC Wainwright cut their FY2024 EPS estimates for shares of OmniAb in a note issued to investors on Thursday, March 21st...
Related Stocks: OABI...
Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on OmniAb (OABI Research Report). The associated price target is $11...
Revenue Drops Amidst Expansion Efforts and Increased R&D SpendingRelated Stocks: OABI...